CIK 0000805928 · Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411301878
- Phone
- (386) 462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $173,940
- in 1 filing, $174K under 10b5-1 plans
Net −$173,940. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-18 | Sandberg Eric Chief Commercial Officer | Shares withheld for taxes | −936 | $14.68 | $14K | 1,595 |
| 2020-02-18 | Freitag Gregory Gene General Counsel | Grant or award | +3,377 | 106,232 | ||
| 2020-02-18 | Freitag Gregory Gene General Counsel | Shares withheld for taxes | −1,002 | $14.68 | $15K | 105,230 |
| 2020-02-18 | Freitag Gregory Gene General Counsel | Grant or award | +1,783 | 107,013 | ||
| 2020-02-18 | Freitag Gregory Gene General Counsel | Shares withheld for taxes | −529 | $14.68 | $8K | 106,484 |
| 2020-02-18 | DeVinney Erick Wayne VP, Clinical&Translational Sc | Grant or award | +5,049 | 49,194 | ||
| 2020-02-18 | DeVinney Erick Wayne VP, Clinical&Translational Sc | Shares withheld for taxes | −1,498 | $14.68 | $22K | 47,696 |
| 2020-02-18 | DeVinney Erick Wayne VP, Clinical&Translational Sc | Grant or award | +1,181 | 48,877 | ||
| 2020-02-18 | DeVinney Erick Wayne VP, Clinical&Translational Sc | Shares withheld for taxes | −351 | $14.68 | $5K | 48,526 |
| 2020-02-18 | Billet Isabelle Chief Strategy and BD Officer | Grant or award | +1,326 | 6,961 | ||
| 2020-02-18 | Billet Isabelle Chief Strategy and BD Officer | Shares withheld for taxes | −440 | $14.68 | $6K | 6,521 |
| 2020-02-18 | MARTINEZ MARIA D. Chief Human Resources Officer | Grant or award | +1,326 | 3,326 | ||
| 2020-02-18 | MARTINEZ MARIA D. Chief Human Resources Officer | Shares withheld for taxes | −394 | $14.68 | $6K | 2,932 |
| 2020-01-01 | Zaderej Karen L. CEO | Grant or award | +40,000 | 632,792 | ||
| 2020-01-01 | Zaderej Karen L. CEO | Returned to the company | −10,112 | $17.34 | $175K | 622,680 |
| 2020-01-01 | Rudelius Robert James Director | Option exercise | +13,000 | $2.75 | $36K | 47,591 |
| 2020-01-01 | Rudelius Robert James Director | Shares withheld for taxes | −1,999 | $17.89 | $36K | 45,592 |
| 2020-01-01 | Rudelius Robert James Director | Option exercise · Director Stock Option (right to purchase) | −13,000 | 0 | ||
| 2019-12-18 | Zaderej Karen L. CEO | Grant or award | +6,250 | 599,530 | ||
| 2019-12-18 | Friedman Mark Louis VP,Regulatory & Quality | Grant or award | +750 | 2,310 |
Page 46 of 69 · 1,376 trades